Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table S1 from Targeting SALL4 with an HLA Class I–Restricted TCR for Cancer Immunotherapy
  1. Home
  2. Publications
  3. Supplementary Table S1 from Targeting SALL4 with an HLA Class I–Restricted TCR for Cancer Immunotherapy

Supplementary Table S1 from Targeting SALL4 with an HLA Class I–Restricted TCR for Cancer Immunotherapy

Authors:
  • MKMyriam Ben Khelil
    Myriam Ben Khelil
  • MFMaxime Fredon
    Maxime Fredon
  • NANawfel Adib
    Nawfel Adib
  • ABAdeline Bouard
    Adeline Bouard
  • MPMarie Perchaud
    Marie Perchaud
  • SASyrine Abdeljaoued
    Syrine Abdeljaoued
  • CMCharles-Frédéric Mantion
    Charles-Frédéric Mantion
  • KAKamal Asgarov
    Kamal Asgarov
  • PGPhilippe Guillaume
    Philippe Guillaume
  • LSLaurie Spehner
    Laurie Spehner
  • ESEvan Seffar
    Evan Seffar
  • MLMarjorie Labesse
    Marjorie Labesse

Open Access
Publisher website
Google Scholar
  • 8 January 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2326-6066.31024175
Abstract
Supplementary Table S1. Homology of SALL4-derived S9V peptide sequence in human proteome
Keywords
  • IMMUNOLOGY
  • IMMUNE RESPONSES TO CANCER
  • TUMOR ANTIGENS/NEOANTIGENS
  • IMMUNOTHERAPY
  • CELLULAR IMMUNOTHERAPY
  • ENGINEERED/CAR T CELLS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.